Global Human Vaccine Market 2022-2026

The market is driven by increase in investments in vaccines segment, public immunization programs funded by governments, and improved public access to information about vaccines

The human vaccine market is poised to grow by $20.37 billion during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period.

This report on the human vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by increase in investments in vaccines segment, public immunization programs funded by governments, and improved public access to information about vaccines.

The human vaccine market analysis includes the route of administration segment and geographic landscape.

The human vaccine market is segmented as below:

By Route of Administration

Intramuscular
Subcutaneous
Oral
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the varied demand for vaccines in high-income and developing countries as one of the prime reasons driving the human vaccine market growth during the next few years. Also, R and D of novel vaccines and advancements in vaccine delivery systems will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report covers the following areas:

Human vaccine market sizing
Human vaccine market forecast
Human vaccine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, the report provides a detailed analysis of several leading human vaccine market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BioNTech SE, CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Moderna Inc., Novavax Inc., Pfizer Inc., Sanofi, and Serum Institute of India Pvt. Ltd. Also, the human vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Route of Administration

5.1 Market segments
Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
5.2 Comparison by Route of Administration
Exhibit 26: Chart on Comparison by Route of Administration
Exhibit 27: Data Table on Comparison by Route of Administration
5.3 Intramuscular - Market size and forecast 2021-2026
Exhibit 28: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
5.4 Subcutaneous - Market size and forecast 2021-2026
Exhibit 32: Chart on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Subcutaneous - Year-over-year growth 2021-2026 (%)
5.5 Oral - Market size and forecast 2021-2026
Exhibit 36: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Oral - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Route of Administration
Exhibit 44: Market opportunity by Route of Administration ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Bavarian Nordic AS
Exhibit 93: Bavarian Nordic AS - Overview
Exhibit 94: Bavarian Nordic AS - Product / Service
Exhibit 95: Bavarian Nordic AS - Key news
Exhibit 96: Bavarian Nordic AS - Key offerings
10.4 CSL Ltd.
Exhibit 97: CSL Ltd. - Overview
Exhibit 98: CSL Ltd. - Business segments
Exhibit 99: CSL Ltd. - Key news
Exhibit 100: CSL Ltd. - Key offerings
Exhibit 101: CSL Ltd. - Segment focus
10.5 Daiichi Sankyo Co. Ltd.
Exhibit 102: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 103: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 104: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 105: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 106: Daiichi Sankyo Co. Ltd. - Segment focus
10.6 GlaxoSmithKline Plc
Exhibit 107: GlaxoSmithKline Plc - Overview
Exhibit 108: GlaxoSmithKline Plc - Business segments
Exhibit 109: GlaxoSmithKline Plc - Key news
Exhibit 110: GlaxoSmithKline Plc - Key offerings
Exhibit 111: GlaxoSmithKline Plc - Segment focus
10.7 Inovio Pharmaceuticals Inc.
Exhibit 112: Inovio Pharmaceuticals Inc. - Overview
Exhibit 113: Inovio Pharmaceuticals Inc. - Product / Service
Exhibit 114: Inovio Pharmaceuticals Inc. - Key offerings
10.8 Merck and Co. Inc.
Exhibit 115: Merck and Co. Inc. - Overview
Exhibit 116: Merck and Co. Inc. - Business segments
Exhibit 117: Merck and Co. Inc. - Key news
Exhibit 118: Merck and Co. Inc. - Key offerings
Exhibit 119: Merck and Co. Inc. - Segment focus
10.9 Mitsubishi Chemical Holdings Corp.
Exhibit 120: Mitsubishi Chemical Holdings Corp. - Overview
Exhibit 121: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibit 122: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibit 123: Mitsubishi Chemical Holdings Corp. - Segment focus
10.10 Pfizer Inc.
Exhibit 124: Pfizer Inc. - Overview
Exhibit 125: Pfizer Inc. - Product / Service
Exhibit 126: Pfizer Inc. - Key news
Exhibit 127: Pfizer Inc. - Key offerings
10.11 Sanofi
Exhibit 128: Sanofi - Overview
Exhibit 129: Sanofi - Business segments
Exhibit 130: Sanofi - Key news
Exhibit 131: Sanofi - Key offerings
Exhibit 132: Sanofi - Segment focus
10.12 Serum Institute of India Pvt. Ltd.
Exhibit 133: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 134: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 135: Serum Institute of India Pvt. Ltd. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 136: Inclusions checklist
Exhibit 137: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 138: Currency conversion rates for US$
11.4 Research methodology
Exhibit 139: Research methodology
Exhibit 140: Validation techniques employed for market sizing
Exhibit 141: Information sources
11.5 List of abbreviations
Exhibit 142: List of abbreviations

List of Exhibits

Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 6: Executive Summary - Chart on Incremental Growth
Exhibit 7: Executive Summary - Data Table on Incremental Growth
Exhibit 8: Executive Summary - Chart on Vendor Market Positioning
Exhibit 9: Parent market
Exhibit 10: Market Characteristics
Exhibit 11: Offerings of vendors included in the market definition
Exhibit 12: Market segments
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibit 26: Chart on Comparison by Route of Administration
Exhibit 27: Data Table on Comparison by Route of Administration
Exhibit 28: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibit 32: Chart on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibit 36: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibit 44: Market opportunity by Route of Administration ($ million)
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
Exhibit 89: Overview on factors of disruption
Exhibit 90: Impact of key risks on business
Exhibit 91: Vendors covered
Exhibit 92: Matrix on vendor position and classification
Exhibit 93: Bavarian Nordic AS - Overview
Exhibit 94: Bavarian Nordic AS - Product / Service
Exhibit 95: Bavarian Nordic AS - Key news
Exhibit 96: Bavarian Nordic AS - Key offerings
Exhibit 97: CSL Ltd. - Overview
Exhibit 98: CSL Ltd. - Business segments
Exhibit 99: CSL Ltd. - Key news
Exhibit 100: CSL Ltd. - Key offerings
Exhibit 101: CSL Ltd. - Segment focus
Exhibit 102: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 103: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 104: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 105: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 106: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibit 107: GlaxoSmithKline Plc - Overview
Exhibit 108: GlaxoSmithKline Plc - Business segments
Exhibit 109: GlaxoSmithKline Plc - Key news
Exhibit 110: GlaxoSmithKline Plc - Key offerings
Exhibit 111: GlaxoSmithKline Plc - Segment focus
Exhibit 112: Inovio Pharmaceuticals Inc. - Overview
Exhibit 113: Inovio Pharmaceuticals Inc. - Product / Service
Exhibit 114: Inovio Pharmaceuticals Inc. - Key offerings
Exhibit 115: Merck and Co. Inc. - Overview
Exhibit 116: Merck and Co. Inc. - Business segments
Exhibit 117: Merck and Co. Inc. - Key news
Exhibit 118: Merck and Co. Inc. - Key offerings
Exhibit 119: Merck and Co. Inc. - Segment focus
Exhibit 120: Mitsubishi Chemical Holdings Corp. - Overview
Exhibit 121: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibit 122: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibit 123: Mitsubishi Chemical Holdings Corp. - Segment focus
Exhibit 124: Pfizer Inc. - Overview
Exhibit 125: Pfizer Inc. - Product / Service
Exhibit 126: Pfizer Inc. - Key news
Exhibit 127: Pfizer Inc. - Key offerings
Exhibit 128: Sanofi - Overview
Exhibit 129: Sanofi - Business segments
Exhibit 130: Sanofi - Key news
Exhibit 131: Sanofi - Key offerings
Exhibit 132: Sanofi - Segment focus
Exhibit 133: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 134: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 135: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibit 136: Inclusions checklist
Exhibit 137: Exclusions checklist
Exhibit 138: Currency conversion rates for US$
Exhibit 139: Research methodology
Exhibit 140: Validation techniques employed for market sizing
Exhibit 141: Information sources
Exhibit 142: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global human vaccine market: Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BioNTech SE, CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Moderna Inc., Novavax Inc., Pfizer Inc., Sanofi, and Serum Institute of India Pvt. Ltd.

Commenting on the report, an analyst said: ''The latest trend gaining momentum in the market is varied demand for vaccines in high-income and developing countries.''

According to the report, one of the major drivers for this market is the increase in investments in vaccines segment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.